The NHS Long Term Plan committed to accelerate the uptake of selected innovative medical devices, diagnostics and digital products to patients faster, by developing the MedTech Funding Mandate policy, which is delivered in partnership with AHSNs.

The technologies that will be supported by the policy in 2021/22 are:

  1. placental growth factor based testing – a blood test to rule out pre-eclampsia in pregnant women
  2. SecurAcath – for securing percutaneous catheters
  3. HeartFlow – creates a 3D model of a patient’s coronary arteries and assesses the extent and location of blockages
  4. gammaCore – a handheld device which alleviates the symptoms of severe cluster headaches.

Find out more about the MedTech Funding Mandate here.